Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-18T02:00:45.205Z Has data issue: false hasContentIssue false
  • English
  • Français

An Important Dilemma: Fibrinolytic Treatment in Bleeding Diathesis

Published online by Cambridge University Press:  07 October 2020

Mustafa Emin Canakci Open the ORCID record for Mustafa Emin Canakci [Opens in a new window] ,
Volkan Ercan Open the ORCID record for Volkan Ercan [Opens in a new window] ,
Nurdan Acar Open the ORCID record for Nurdan Acar [Opens in a new window]  and
Serdar Efe Open the ORCID record for Serdar Efe [Opens in a new window]
Mustafa Emin Canakci*
Affiliation:
Emergency Department, Eskisehir Osmangazi University School of Medicine, Eskisehir, Turkey
Volkan Ercan
Affiliation:
Intensive Care Unit, Eskisehir City Hospital, Eskisehir, Turkey
Nurdan Acar
Affiliation:
Emergency Department, Eskisehir Osmangazi University School of Medicine, Eskisehir, Turkey
Serdar Efe
Affiliation:
Intensive Care Unit, Eskisehir City Hospital, Eskisehir, Turkey
*
Correspondence: Mustafa Emin Canakci, MD Emergency Department Eskisehir Osmangazi University School of MedicineEskisehir, Turkey Prof. Dr. Nabi Avcı Boulevard, No:4, Meselik, Odunpazarı, 26040 E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Pulmonary embolism is a clinical condition with high mortality rates in all age groups. The treatment includes anticoagulation and fibrinolytic therapy, and clinical management is challenging in cases of bleeding diathesis. Sepsis-induced coagulopathy (SIC), which has been recently defined to cause disruption of coagulation cascade accompanied by organ dysfunctions, is regarded as a major cause of mortality. It is noteworthy that there is no decrease in fibrinogen levels, unlike disseminated intravascular coagulopathy (DIC). This study aimed to present the management of a 70-year-old female patient who was admitted to emergency department with atypical complaints and diagnosed with pulmonary embolism due to deep vein thrombosis and septic shock. The clinical success of fibrinolytic therapy following the administration of fresh frozen plasma (FFP), although the patient had elevated international normalized ratio (INR), is presented in this case report. Since elevated INR and thrombocytopenia, which are observed in SIC, are caused by the inhibition of fibrinolysis, fibrinolytic therapy can be a rational treatment choice considering the profit/loss rate.

Keywords

fibrinolytic treatmentfresh frozen plasmapulmonary embolismultrasonography
Type
Case Report
Information
Prehospital and Disaster Medicine , Volume 35 , Issue 6 , December 2020 , pp. 690 - 692
Check for updates
Copyright
© The Author(s), 2020. Published by Cambridge University Press on behalf of the World Association for Disaster and Emergency Medicine

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alotaibi, GS, Wu, C, Senthilselvan, A, McMurtry, MS. Secular trends in incidence and mortality of acute venous thromboembolism: the AB-VTE population-based study. Am J Med. 2016;129(8):879 Google ScholarPubMed
Stein, PD, Beemath, A, Matta, F, et al. Clinical characteristics of patients with acute pulmonary embolism: data from PIOPED II. Am J Med. 2007;120(10):871–879.CrossRefGoogle ScholarPubMed
Konstantinides, SV, Meyer, G, Becattini, C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543–603.Google Scholar
Taylor, FB, Toh, CH, Hoots, WK, Wada, H, Levi, M; Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86(5):1327–1330.CrossRefGoogle Scholar
Iba, T, Nisio, MD, Levy, JH, Kitamura, N, Thachil, J. New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey. BMJ Open. 2017;7(9):e017046.CrossRefGoogle ScholarPubMed
Lyons, PG, Micek, ST, Hampton, N, Kollef, MH. Sepsis-associated coagulopathy severity predicts hospital mortality. Crit Care Med. 2018;46(5):736–742.CrossRefGoogle ScholarPubMed
Iba, T, Levi, M, Levy, JH. Sepsis-induced coagulopathy and disseminated intravascular coagulation. Semin Thromb Hemost. 2020;46(1):89–95.Google ScholarPubMed
Iba, T, Levy, JH. Sepsis-induced coagulopathy and disseminated intravascular coagulation. Anesthesiology. 2020;132(5):1238–1245.CrossRefGoogle ScholarPubMed
Rangel-Frausto, MS, Pittet, D, Costigan, M, Hwang, T, Davis, CS, Wenzel, RP. The natural history of the Systemic Inflammatory Response Syndrome (SIRS): a prospective study. JAMA. 1995;273(2):117–123.Google ScholarPubMed
Aujesky, D, Obrosky, DS, Stone, RA, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med. 2005;172(8):1041–1046.CrossRefGoogle ScholarPubMed
Fengler, BT, Brady, WJ. Fibrinolytic therapy in pulmonary embolism: an evidence-based treatment algorithm. Am J Emerg Med. 2009;27(1):84–95.Google Scholar
Wojciechowski, VV, Calina, D, Tsarouhas, K, et al. A guide to acquired vitamin K coagulopathy diagnosis and treatment: the Russian perspective. DARU J Pharm Sci. 2017;25(1):10.CrossRefGoogle ScholarPubMed
Gando, S, Iba, T, Eguchi, Y, et al. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med. 2006;34(3):625–631.CrossRefGoogle ScholarPubMed
Iba, T, Umemura, Y, Watanabe, E, Wada, T, Hayashida, K, Kushimoto, S. Diagnosis of sepsis-induced disseminated intravascular coagulation and coagulopathy. Acute Med Surg. 2019;6(3):223–232.Google ScholarPubMed
Iba, T, Levy, JH. Derangement of the endothelial glycocalyx in sepsis. J Thrombos Haemostas. 2019;17(2):283–294.CrossRefGoogle ScholarPubMed